The FDA approved an unproven Alzheimer's drug, and its manufacturer priced it in the stratosphere. Result: Medicare members get higher premiums.
The FDA’s approval of an Alzheimer’s drug of dubious value will throw U.S. healthcare spending into crisis.
The author of those words, neurologist David Knopman of the Mayo Clinic, resigned after the FDA’s approval. Two other members also resigned, including Aaron Kesselheim of Harvard Medical School, who called the FDA’s action “probably the worst drug approval decision in recent U.S. history” in his resignation letter.
Biogen executives were shameless about the potential profits they expect to be reaped from the full price. “We believe Aduhelm represents a significant long-term growth driver with modest revenue in 2021 ramping to a multibillion-dollar U.S. sales opportunity over the next several years,” Chief Financial OfficerThe company’s stock soared by about 45%, to a peak of $414.71, in the days after the FDA approval, though it has since fallen back to earth.
It gets worse. Because the clinical trials revealed that about 30% of patients receiving a high dose of Aduhelm experienced brain swelling, patients will have to undergo regular MRI tests to watch out for this dangerous side effect. They’ll have to pay their 20% share of those, too.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Philips shares tumble as FDA raises concern about silicone foamKoninklijke Philips undefinedundefined was on track for its worst single session in 19 years, falling 9.6%, after the Food and Drug Administration's...
Read more »
States, NYC move ahead with boosters for all as FDA deliberatesNew York City, California, Colorado and New Mexico are offering booster shots to all adults, before the FDA and CDC have signed off.
Read more »
Biden Nominates Pick for FDA Head…FinallyAfter a months-long hunt, Biden names Dr. Robert Califf as his choice to head the FDA
Read more »
Analysis: COP26 message to business: clean up to cash inThe hard-fought Glasgow Climate Pact sent a clear message to global companies and executives: reassess business strategies and carbon footprints to reap monetary rewards, or lag and risk losses.
Read more »
Hailey Bieber Was Elegant In a White Saint Laurent Column Gown at the LACMA GalaHailey Bieber Was Elegant In A White Saint Laurent Column Gown At The LACMA Gala
Read more »